<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8" />
        <title>Indicator 3.3.3: Malaria incidence per 1,000 population  -> Indicator 3.3.3: Malaria incidence per 1,000 population</title>
        <link rel="stylesheet" type="text/css" href="https://cdn.jsdelivr.net/npm/diff2html/bundles/css/diff2html.min.css" />
        <script type="text/javascript" src="https://cdn.jsdelivr.net/npm/diff2html/bundles/js/diff2html.min.js"></script>
        <style>
            html {
                -webkit-print-color-adjust: exact;
            }
            .d2h-code-line-ctn {
                white-space: normal;
            }
            ins, del, h1 p, h2 p, h3 p, h4 p, h5 p, h6 p {
                display: inline;
            }
            ins.mod, ins.diffmod + li {
                background: khaki;
            }
            ins.diffmod {
                background: lightgreen;
            }
            del.diffmod, del.diffdel {
                background: salmon;
            }
            ins.diffins {
                background: lightgreen;
            }
            .sdg-diff-section {
                padding: 20px;
                margin: 20px 0;
                background: #EEE;
            }
            header {
                font-size: 1.2em;
            }
            
        .instructions {
            border: 1px solid black;
            background: lightyellow;
            padding: 20px;
        }
    
        </style>
        
    </head>
    <body>
        <h1>Indicator 3.3.3: Malaria incidence per 1,000 population  -> Indicator 3.3.3: Malaria incidence per 1,000 population</h1>
        
        <header>
            
        <p>
            This comparison shows additions and deletions to metadata files in simple,
            human-readable format. This view may be helpful to general users.
        </p>
    
        </header>
        
        <p>
        
            <ins class="diffmod">2022-03-31</ins><br>
            <del class="diffmod">2021-02-01</del>
        
        </p>
        <div class="sdg-diff-section"><div class="d2h-file-header"><div class="d2h-file-name-wrapper"><div class="d2h-file-name">0.c. Indicator (SDG_INDICATOR)</div></div></div><p>Indicator 3.3.3: Malaria incidence per 1,000 population<del class="diffdel">&nbsp;</del></p></div><div class="sdg-diff-section"><div class="d2h-file-header"><div class="d2h-file-name-wrapper"><div class="d2h-file-name">0.e. Metadata update (META_LAST_UPDATE)</div></div></div><p><del class="diffmod">2021</del><ins class="diffmod">2022</ins>-<del class="diffmod">02</del><ins class="diffmod">03</ins>-<del class="diffmod">01</del></p><ins class="diffmod">31</ins></div><div class="sdg-diff-section"><div class="d2h-file-header"><div class="d2h-file-name-wrapper"><div class="d2h-file-name">0.g. International organisations(s) responsible for global monitoring (SDG_CUSTODIAN_AGENCIES)</div></div></div><p>Global Malaria Programme at World Health Organization<del class="diffdel">&nbsp;</del>(WHO)<del class="diffdel">&nbsp;</del></p></div><div class="sdg-diff-section"><div class="d2h-file-header"><div class="d2h-file-name-wrapper"><div class="d2h-file-name">2.a. Definition and concepts (STAT_CONC_DEF)</div></div></div><p><strong>Definition:</strong> </p>
<p>Incidence of malaria is defined as the number of new cases of malaria per 1,000 people at risk each year. </p>
<p><strong>Concepts:</strong><del class="diffdel">&nbsp;</del></p>
<p><del class="diffmod">Case</del><ins class="diffmod">A case</ins> of malaria is defined as the occurrence of malaria infection in a person<ins class="diffins">&nbsp;in</ins> whom the presence of malaria parasites in the blood has been confirmed by a diagnostic test. The population considered is the population at risk of the disease.</p><ins class="diffins">
</ins><p> </p></div><div class="sdg-diff-section"><div class="d2h-file-header"><div class="d2h-file-name-wrapper"><div class="d2h-file-name">3.b. Data collection method (COLL_METHOD)</div></div></div><p>The official counterpart for each country is the National Malaria Control Program at the Ministry of Health.<del class="diffdel">&nbsp;</del></p></div><div class="sdg-diff-section"><div class="d2h-file-header"><div class="d2h-file-name-wrapper"><div class="d2h-file-name">3.c. Data collection calendar (FREQ_COLL)</div></div></div><p>Data is collected every year.<del class="diffdel">&nbsp;</del></p></div><div class="sdg-diff-section"><div class="d2h-file-header"><div class="d2h-file-name-wrapper"><div class="d2h-file-name">3.d. Data release calendar (REL_CAL_POLICY)</div></div></div><p>Data is released yearly.<del class="diffdel">&nbsp;</del></p></div><div class="sdg-diff-section"><div class="d2h-file-header"><div class="d2h-file-name-wrapper"><div class="d2h-file-name">3.e. Data providers (DATA_SOURCE)</div></div></div><p>The National Malaria Control Program is the responsible to collect the information at each country.<del class="diffdel">&nbsp;</del></p></div><div class="sdg-diff-section"><div class="d2h-file-header"><div class="d2h-file-name-wrapper"><div class="d2h-file-name">3.f. Data compilers (COMPILING_ORG)</div></div></div><p>The Surveillance, Monitoring and Evaluation Unit of the Global Malaria Control Programme is the responsible to compile and process all the relevant information. National estimates for some countries are estimated in collaboration with the <del class="diffdel">Oxford University (</del>Malaria Atlas Project<del class="diffmod">)</del><ins class="diffmod">&nbsp;which has been designated a WHO collaborating centre in geospatial disease modelling</ins>.<del class="diffdel">&nbsp;</del></p></div><div class="sdg-diff-section"><div class="d2h-file-header"><div class="d2h-file-name-wrapper"><div class="d2h-file-name">3.g. Institutional mandate (INST_MANDATE)</div></div></div><p>The Global technical strategy and targets for malaria 2016&#x2013;2030 was adopted by<del class="diffdel">&nbsp;the</del> The 68 World Health Assembly (<a href="https://apps.who.int/iris/bitstream/handle/10665/253469/A68_R1_REC1-en.pdf?sequence=1&amp;isAllowed=y">https://apps.who.int/iris/bitstream/handle/10665/253469/A68_R1_REC1-en.pdf?sequence=1&amp;isAllowed=y</a>). The Assembly requested WHO to monitor the progress toward the GTS milestones and targets. The World Malaria Report is the process by which the GTS is monitored by country, WHO region and globally.<del class="diffdel">&nbsp;</del></p></div><div class="sdg-diff-section"><div class="d2h-file-header"><div class="d2h-file-name-wrapper"><div class="d2h-file-name">4.a. Rationale (RATIONALE)</div></div></div><p>To measure trends in malaria morbidity and to identify locations where the risk of disease is highest. With this information, programmes can respond to unusual trends, such as epidemics, and direct resources to the populations most in need. <del class="diffmod">This</del><ins class="diffmod">These</ins> data also serves to inform global resource allocation for malaria such as when defining eligibility criteria for Global Fund finance.<del class="diffdel">&nbsp;</del></p></div><div class="sdg-diff-section"><div class="d2h-file-header"><div class="d2h-file-name-wrapper"><div class="d2h-file-name">4.b. Comment and limitations (REC_USE_LIM)</div></div></div><p>The estimated incidence can differ from the incidence reported by a Ministry of Health which can be affected by:<del class="diffdel">&nbsp;</del></p>
<ul>
  <li>the completeness of reporting: the number of reported cases can be lower than the estimated cases if the percentage of health facilities reporting in a month is less than 100%<del class="diffdel">&nbsp;</del></li>
  <li>the extent of malaria diagnostic testing (the number of slides examined or RDTs performed)<del class="diffdel">&nbsp;</del></li>
  <li>the use of private health facilities which are usually not included in reporting systems.<del class="diffdel">&nbsp;</del></li>
  <li>the indicator is estimated only where malaria transmission occurs.<del class="diffdel">&nbsp;</del></li>
</ul></div><div class="sdg-diff-section"><div class="d2h-file-header"><div class="d2h-file-name-wrapper"><div class="d2h-file-name">4.c. Method of computation (DATA_COMP)</div></div></div><p>Malaria incidence (1) is expressed as the number of new cases per 100,000 population per year with the population of a country derived from projections made by the UN Population Division and the total proportion at risk estimated by a country&#x2019;s National Malaria Control Programme. More specifically, the country estimates what is the total proportion of the population at risk of malaria and then, for each year, the total population at risk is estimated as the UN Population for that year, times the proportion of the population at risk at baseline.</p><del class="diffmod">
</del><p><ins class="diffmod">&nbsp;The same proportion of the population at risk is used for the entire time series to ensure comparability of estimates through time.</ins> </p>
<p>The total number of new cases, T, is estimated from the number of malaria cases reported by a Ministry of Health which is adjusted to take into account (i) incompleteness in reporting systems (ii) patients seeking treatment in the private sector, self-medicating or not seeking treatment at all, and (iii) potential over-diagnosis through the lack of laboratory confirmation of cases. The procedure, which is described in the <em>World malaria report 2009<ins class="diffins">&nbsp;</ins></em><del class="diffdel">&nbsp;</del>(2), combines data reported by NMCPs (reported cases, reporting completeness and likelihood that cases are parasite positive) with data obtained from nationally representative household surveys on health-service use. Briefly,<del class="diffdel">&nbsp;</del></p><del class="diffdel">
</del><p><del class="diffdel">&nbsp;</del></p>
<p>T=(a+(c &#xD7; e)/d)&#xD7;(1+h/g+((1&#x2212;g&#x2212;h)/2)/g)</p>
<p><del class="diffdel">&nbsp;</del></p><del class="diffdel">
</del><p>where:<del class="diffdel">&nbsp;</del><br>a is the number of malaria cases confirmed in public sector<del class="diffdel">&nbsp;</del><br>b is the number of suspected cases tested<del class="diffdel">&nbsp;</del><br>c is the number of presumed cases (not tested but treated as malaria)<del class="diffdel">&nbsp;</del><br><em>d </em>is the reporting completeness<del class="diffdel">&nbsp;</del><br><em>e </em>is the test positivity rate (malaria positive fraction) = a/b<del class="diffdel">&nbsp;</del><br><em>f </em>is the estimated cases in public sector, calculated by (a + (c x <em>e</em>))/<em>d</em><del class="diffdel">&nbsp;</del><br><em>g </em>is the fraction seeking treatment in public sector<del class="diffdel">&nbsp;</del><br><em>h </em>is the fraction seeking treatment in private sector<del class="diffdel">&nbsp;</del><br><em>i </em>is the fraction not seeking treatment, calculated by (1-<em>g</em>-<em>h</em>)/2<del class="diffdel">&nbsp;</del><br><em>j </em>is the cases in private sector, calculated as <em>f x h/g</em><del class="diffdel">&nbsp;</del><br><em>k </em>is the cases not in private and not in public, calculated by <em>f </em>x <em>i</em>/<em>g</em><del class="diffdel">&nbsp;</del><br><em>T </em>is total cases, calculated by <em>f </em>+ <em>j </em>+ <em>k</em><del class="diffdel">. </del></p><del class="diffdel">
</del><p> </p>
<p>To estimate the uncertainty around the number of cases, the test positivity rate was assumed to have a normal distribution centred on the <em>Test positivity rate</em> value and standard deviation defined as<del class="diffdel">&nbsp;</del></p>
<p>0.244 &#xD7; Test positivity rate<sup>0.5547</sup></p>
<p><del class="diffdel">&nbsp;</del>and truncated to be in the range 0, 1. Reporting completeness was assumed to have one of three distributions, depending on the range or value reported by the NMCP. If the <del class="diffmod">range</del><ins class="diffmod">value</ins> was<ins class="diffins">&nbsp;reported as a range</ins> greater than 80%<ins class="diffins">,</ins> the distribution was assumed to be triangular, with limits of 0.8 and 1<ins class="diffins">.0,</ins> and the peak at 0.8. If the <del class="diffmod">range</del><ins class="diffmod">value</ins> was <del class="diffmod">greater</del><ins class="diffmod">more</ins> than 50% <del class="diffmod">then</del><ins class="diffmod">but less than or equal to 80%,</ins> the distribution was assumed to be rectangular, with limits of 0.5 and 0.8. Finally, if the <del class="diffmod">range</del><ins class="diffmod">value</ins> was <del class="diffmod">lower</del><ins class="diffmod">less</ins> than <ins class="diffins">or equal to </ins>50%<ins class="diffins">,</ins> the distribution was assumed to be triangular, with limits of 0 and 0.5<ins class="diffins">,</ins> and the peak at 0.5 <em><ins class="mod">(3)<del class="diffmod">&nbsp;</del></ins></em>. If the reporting completeness was reported as a value and was <del class="diffmod">greater</del><ins class="diffmod">more</ins> than 80%, a beta distribution was assumed<ins class="diffins">,</ins> with a mean value of the reported value (maximum of 95%) and confidence intervals (CIs) of 5% <del class="diffmod">round</del><ins class="diffmod">around</ins> the mean value. The <del class="diffmod">proportions</del><ins class="diffmod">fraction</ins> of children <ins class="diffins">brought </ins>for<del class="diffdel">&nbsp;whom</del> care <del class="diffmod">was</del><ins class="diffmod">in</ins> <del class="diffmod">sought</del><ins class="diffmod">the public sector and</ins> in the private sector <del class="diffmod">and in the public sector were</del><ins class="diffmod">was</ins> assumed to have a beta distribution, with the mean value being the estimated value in the survey and the standard deviation <ins class="diffins">being </ins>calculated from the range of the estimated 95% <del class="diffmod">confidence intervals (CI) divided by 4</del><ins class="diffmod">CIs</ins>. The <del class="diffmod">proportion</del><ins class="diffmod">fraction</ins> of children <ins class="diffins">not brought </ins>for <del class="diffdel">whom </del>care<del class="diffdel">&nbsp;was not sought</del> was assumed to have a rectangular distribution, with the lower limit <ins class="diffins">being </ins>0 and<ins class="diffins">&nbsp;the</ins> upper limit calculated as 1 minus the proportion that <del class="diffmod">sought</del><ins class="diffmod">were brought for</ins> care in <ins class="diffins">the </ins>public <del class="diffmod">or</del><ins class="diffmod">and private sectors. The three distributions (fraction seeking treatment in public sector, fraction seeking treatment in</ins> private sector<ins class="diffins">&nbsp;only and fraction not seeking treatment) were constrained to add up to 1</ins>.<del class="diffdel">&nbsp;</del></p>
<p><ins class="diffins">Sector-specific</ins> </p><del class="diffmod">
</del><p><del class="diffmod">Values for the proportion </del><ins class="diffmod">care-</ins>seeking <del class="diffmod">care</del><ins class="diffmod">fractions</ins> were linearly interpolated between the years that <del class="diffmod">have</del><ins class="diffmod">had</ins> a survey<del class="diffdel">,</del> and were extrapolated for the years before the first or after the last survey. <del class="diffmod">Missing</del><ins class="diffmod">The</ins> <del class="diffmod">values</del><ins class="diffmod">parameters</ins> <del class="diffmod">for</del><ins class="diffmod">used</ins> <del class="diffmod">the</del><ins class="diffmod">to</ins> <del class="diffmod">distributions</del><ins class="diffmod">propagate uncertainty around these fractions</ins> were <ins class="diffins">also </ins>imputed <del class="diffmod">using</del><ins class="diffmod">in</ins> a <del class="diffmod">mixture</del><ins class="diffmod">similar</ins> <del class="diffmod">of the distribution of the country, with equal probability for the years where values were present</del><ins class="diffmod">way</ins> or, if there was no value <del class="diffdel">at all </del>for any year in the country<ins class="diffins">&nbsp;or area</ins>,<ins class="diffins">&nbsp;were imputed as</ins> a mixture of the <del class="diffmod">distribution</del><ins class="diffmod">distributions</ins> of the region for that year<ins class="diffins">. CIs were obtained from 10 000 draws of the convoluted distributions</ins>. The data were analysed using the R statistical software (4). <del class="diffmod">Confidence</del><ins class="diffmod">This</ins> <del class="diffmod">intervals</del><ins class="diffmod">method</ins> <del class="diffmod">were</del><ins class="diffmod">was</ins> <del class="diffmod">obtained</del><ins class="diffmod">used</ins> <del class="diffmod">from</del><ins class="diffmod">was</ins> <del class="diffmod">10000</del><ins class="diffmod">used</ins> <del class="diffmod">drawns</del><ins class="diffmod">for</ins> <del class="diffmod">of</del><ins class="diffmod">countries and areas outside</ins> the <del class="diffmod">convoluted</del><ins class="diffmod">WHO</ins> <del class="diffmod">distributions.</del><ins class="diffmod">African</ins> <del class="diffmod">(</del><ins class="diffmod">Region, and for low-transmission countries and areas in the African Region: </ins>Afghanistan, Bangladesh, Bolivia (Plurinational State of), Botswana, Brazil, Cambodia, Colombia, <ins class="diffins">the </ins>Dominican Republic, Eritrea, Ethiopia, French Guiana,<ins class="diffins">&nbsp;the</ins> Gambia, Guatemala, Guyana, Haiti, Honduras, India, Indonesia,<ins class="diffins">&nbsp;the</ins> Lao People&#x2019;s Democratic Republic, Madagascar, Mauritania, Myanmar, Namibia, Nepal, Nicaragua, Pakistan, Panama, Papua New Guinea, Peru, <ins class="diffins">the </ins>Philippines, Rwanda, Senegal, Solomon Islands, Timor-Leste, Vanuatu, Venezuela (Bolivarian Republic of), Viet Nam, Yemen and Zimbabwe<ins class="diffins">. Bangladesh, Bolivia (plurinational State of), Botswana, Brazil, Colombia, Dominican Republic, French Guiana, Guatemala, Guyana, Haiti, Honduras, Myanmar (since 2013), Rwanda, and Venezuela (Bolivarian Republic of) report cases from the private and public sector together; therefore, no adjustment for private sector seeking treatment was made while for Indonesia, 25% of the private was assumed to be reported in the public sector since 2017</ins>. For India, the values were obtained at subnational level using the same methodology, but adjusting the private sector for an additional factor due to the active case detection, estimated as the ratio of the test positivity rate in the active case detection over the test positivity rate for the passive case detection. This factor was assumed to have a normal distribution, with mean value and standard deviation calculated from the values reported in 2010. <del class="diffmod">Bangladesh</del><ins class="diffmod">An additional adjustment was applied in several states in India</ins>, <del class="diffmod">Bolivia</del><ins class="diffmod">to</ins> <del class="diffmod">(plurinational</del><ins class="diffmod">control</ins> <del class="diffmod">State of), Botswana, Brazil, Colombia, Dominican Republic, French Guiana, Guatemala, Guyana, Haiti, Honduras, Myanmar (since 2013), Rwanda, and Venezuela (Bolivarian Republic of) report cases from</del><ins class="diffmod">for</ins> the <del class="diffmod">private</del><ins class="diffmod">reductions</ins> <del class="diffmod">and</del><ins class="diffmod">in</ins> <del class="diffmod">public</del><ins class="diffmod">reported</ins> <del class="diffmod">sector</del><ins class="diffmod">testing</ins> <del class="diffmod">together;</del><ins class="diffmod">rates</ins> <del class="diffmod">therefore,</del><ins class="diffmod">associated</ins> <del class="diffmod">no</del><ins class="diffmod">with</ins> <del class="diffmod">adjustment</del><ins class="diffmod">disruptions</ins> <del class="diffmod">for</del><ins class="diffmod">in</ins> <del class="diffmod">private</del><ins class="diffmod">health</ins> <del class="diffmod">sector</del><ins class="diffmod">services</ins> <del class="diffmod">seeking</del><ins class="diffmod">related</ins> <del class="diffmod">treatment was made while for Indonesia, 25% of</del><ins class="diffmod">to</ins> the <del class="diffmod">private</del><ins class="diffmod">COVID-19</ins> <del class="diffmod">was assume to be reported in the public sector since 2017</del><ins class="diffmod">pandemic</ins>.<del class="diffdel">&nbsp;</del></p><del class="diffdel">
</del><p> </p>
<p>For some high-transmission African countries the quality of case reporting is considered insufficient for the above formulae to be applied. In such cases estimates of the number of malaria cases are derived from information on parasite prevalence obtained from household surveys. First, data on parasite prevalence from nearly 60 000 survey records were assembled within a spatiotemporal Bayesian geostatistical model, along with environmental and sociodemographic covariates, and data distribution on interventions such as ITNs, antimalarial drugs and IRS. The geospatial model enabled predictions of Plasmodium falciparum prevalence in children aged 2&#x2013;10 years, at a resolution of 5 &#xD7; 5 km2, throughout all malaria endemic African countries for each year from 2000 to 2016 (see <a href="https://malariaatlas.org/"><ins class="mod"><del class="diffmod">http</del><ins class="diffmod">https</ins>://<del class="diffmod">www</del><ins class="diffmod">malariaatlas</ins>.<del class="diffmod">map.ox.ac.uk</del><ins class="diffmod">org</ins>/<del class="diffdel">making-maps/</del></ins></a> for methods on the development of maps by the Malaria Atlas Project). Second, an ensemble model was developed to predict malaria incidence as a function of parasite prevalence. The model was then applied to the estimated parasite prevalence in order to obtain estimates of the malaria case incidence at 5 &#xD7; 5 <del class="diffmod">km</del><ins class="mod"><del class="diffmod">2</del></sup><ins class="diffmod">km2</ins> resolution for each year from 2000 to <del class="diffmod">2016</del><ins class="diffmod">2020</ins>. Data for each 5 &#xD7; 5 <del class="diffmod">km</del><ins class="mod"><del class="diffmod">2</del></sup><ins class="diffmod">km2</ins> area were then aggregated within country and regional boundaries to obtain both national and regional estimates of malaria cases (5). <ins class="diffins">In 2020, additional cases estimated using this method were added, to account for the disruptions in malaria prevention, diagnostic and treatment services as a result of the COVID-19 pandemic and other events that occurred during this year. Disruption information was reported per country and was obtained from the national pulse surveys on continuity of essential health services during the COVID-19 pandemic conducted by WHO </ins>(<ins class="diffins">first round in May&#x2013;July 2020 and second in January&#x2013;March 2021). This method was applied in the following countries: </ins>Angola, Benin, Burkina Faso, Burundi, Cameroon, <ins class="diffins">the </ins>Central African Republic, Chad, <ins class="diffins">the </ins>Congo, C&#xF4;te d<del class="diffmod">&apos;</del><ins class="diffmod">&#x2019;</ins>Ivoire,<ins class="diffins">&nbsp;the</ins> Democratic Republic of the Congo, Equatorial Guinea, Gabon, Ghana, Guinea, Guinea-Bissau, Kenya, Liberia, Malawi, Mali, Mozambique, <ins class="diffins">the </ins>Niger, Nigeria, Sierra Leone, Somalia, South Sudan, <ins class="diffins">the </ins>Sudan, Togo, Uganda,<ins class="diffins">&nbsp;the</ins> United Republic of Tanzania and Zambia<del class="diffdel">) </del></p>
<p>For most of the elimination or near elimination countries, the number of indigenous cases registered by the NMCPs are reported without further adjustments. (Algeria, Argentina, Armenia, Azerbaijan, Belize, Bhutan, Cabo Verde, China, Comoros, Costa Rica, Democratic People&#x2019;s Republic of Korea, Djibouti, Ecuador, Egypt, El Salvador, Eswatini, Georgia, Iran (Islamic Republic of), Iraq, Kazakhstan, Kyrgyzstan, Malaysia, Mexico, Morocco, Oman, Paraguay, Republic of Korea, Sao Tome and Principe, Saudi Arabia, South Africa, Sri Lanka, Suriname, Syrian Arab Republic, Thailand, Turkey, Turkmenistan, United Arab Emirates and Uzbekistan). </p></div><div class="sdg-diff-section"><div class="d2h-file-header"><div class="d2h-file-name-wrapper"><div class="d2h-file-name">4.f. Treatment of missing values (i) at country level and (ii) at regional level (IMPUTATION)</div></div></div><ul>
  <li><strong>At country level<ins class="diffins">&nbsp;</ins></strong></li>
</ul>
<p>For missing values of the parameters (test positivity rate and reporting completeness) a distribution based on a mixture of the distribution of the available values is used, if any value exists for the country or from the region otherwise. Values for health seeking behaviour parameters are imputed by linear interpolation of the values when the surveys where made or extrapolation of the first or last survey. When no reported data is available the number of cases is interpolated taking into account the population growth. </p>
<p> </p>
<ul>
  <li><strong>At regional and global levels<ins class="diffins">&nbsp;</ins></strong></li>
</ul>
<p>Not Applicable </p>
<p> </p></div><div class="sdg-diff-section"><div class="d2h-file-header"><div class="d2h-file-name-wrapper"><div class="d2h-file-name">4.g. Regional aggregations (REG_AGG)</div></div></div><p>Number of cases are aggregated by region, and uncertainty obtained from the aggregation of each country&#x2019;s distribution. Population at risk is aggregated without any further adjustment. Estimation at global level <del class="diffmod">are</del><ins class="diffmod">is</ins> obtained from aggregation of the <del class="diffmod">region</del><ins class="diffmod">regional</ins> values.</p></div><div class="sdg-diff-section"><div class="d2h-file-header"><div class="d2h-file-name-wrapper"><div class="d2h-file-name">4.i. Quality management (QUALITY_MGMNT)</div></div></div><p>Burden estimates are first reviewed internally by GMP and WHO regional and country offices. <del class="diffmod">This</del><ins class="diffmod">These</ins> are then <del class="diffmod">share</del><ins class="diffmod">shared</ins> to country for validation. Final approval<ins class="diffins">&nbsp;is</ins> received from the WHO division of Data, Analytics.</p></div><div class="sdg-diff-section"><div class="d2h-file-header"><div class="d2h-file-name-wrapper"><div class="d2h-file-name">4.j. Quality assurance (QUALITY_ASSURE)</div></div></div><p>We collect data using a standardize form depending on the status of malaria control, elimination or prevention of reintroduction. We work closely with the collaborators centres and external reviewers to assure quality. </p><ins class="diffins">
</ins><p><ins class="diffins">&nbsp;</ins></p></div><div class="sdg-diff-section"><div class="d2h-file-header"><div class="d2h-file-name-wrapper"><div class="d2h-file-name">4.k. Quality assessment (QUALITY_ASSMNT)</div></div></div><p>We perform internal validation for outliers and completeness and raise queries to countries through the regional offices for clarification. When necessary we rely on data quality assessment information from external sources such as partners working in malaria <del class="diffmod">monitor</del><ins class="diffmod">monitoring</ins> and evaluation. </p></div><div class="sdg-diff-section"><div class="d2h-file-header"><div class="d2h-file-name-wrapper"><div class="d2h-file-name">5. Data availability and disaggregation (COVERAGE)</div></div></div><p><strong>Data availability: </strong></p>
<p>109 countries<ins class="diffins">&nbsp;</ins></p><ins class="diffins">
</ins><p><ins class="diffins">&nbsp;</ins></p>
<p><strong>Time series:<ins class="diffins">&nbsp;</ins></strong></p>
<p>Annually <del class="diffmod">from</del><ins class="diffmod">since</ins> 2000<ins class="diffins">&nbsp;</ins></p>
<p><strong>Disaggregation:</strong></p>
<p>The indicator is estimated at country level.<ins class="diffins">&nbsp;</ins></p></div><div class="sdg-diff-section"><div class="d2h-file-header"><div class="d2h-file-name-wrapper"><div class="d2h-file-name">6. Comparability/deviation from international standards (COMPARABILITY)</div></div></div><p><strong>Sources of discrepancies:</strong><ins class="diffins">&nbsp;</ins></p>
<p>The estimated incidence can differ from the incidence reported by a Ministry of Health which can be affected by: </p>
<ul>
  <li>the completeness of reporting: the number of reported cases can be lower than the estimated cases if the percentage of health facilities reporting in a month is less than 100% </li>
  <li>the extent of malaria diagnostic testing (the number of slides examined or RDTs performed) </li>
  <li>the use of private health facilities which are usually not included in reporting systems. </li>
</ul></div><div class="sdg-diff-section"><div class="d2h-file-header"><div class="d2h-file-name-wrapper"><div class="d2h-file-name">7. References and Documentation (OTHER_DOC)</div></div></div><p><strong>URL:</strong><ins class="diffins">&nbsp;</ins></p>
<p><a href="https://www.who.int/publications/i/item/9789240015791">https://www.who.int/<del class="diffmod">publications</del><ins class="diffmod">teams</ins>/<del class="diffmod">i</del><ins class="diffmod">global-malaria-programme</ins>/<del class="diffmod">item</del><ins class="diffmod">reports</ins>/<del class="diffmod">9789240015791</del></a><ins class="diffmod">world-malaria-report-2021</ins></p><ins class="diffmod">
</ins><p><ins class="diffmod">&nbsp;</ins></p>
<p><strong>References:</strong><ins class="diffins">&nbsp;</ins></p>
<p>1. World Health Organization. World Malaria Report <del class="diffmod">2020 2020</del><ins class="diffmod">2021</ins>. </p>
<p>2. World Health Organization. World Malaria Report 2008 [Internet]. Geneva: World Health Organization; 2008. Available from: http://apps.who.int/iris/bitstream/10665/43939/1/9789241563697_eng.pdf </p>
<p>3. Cibulskis RE, Aregawi M, Williams R, Otten M, Dye C. Worldwide Incidence of Malaria in 2009: Estimates, Time Trends, and a Critique of Methods. Mueller I, editor. PLoS Med. 2011 Dec 20;8(12):e1001142.<ins class="diffins">&nbsp;</ins></p>
<p>4. R Core Team. R: A Language and Environment for Statistical Computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2020. Available from: http://www.R-project.org/<ins class="diffins">&nbsp;</ins></p><ins class="diffins">
</ins><p> </p>
<p>5. Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015 Oct 8;526(7572):207&#x2013;11.<ins class="diffins">&nbsp;</ins></p></div><div class="sdg-diff-section"><div class="d2h-file-header"><div class="d2h-file-name-wrapper"><div class="d2h-file-name">0.d. Series (SDG_SERIES_DESCR)</div></div></div><p><ins class="diffins">Not applicable</ins></p></div>
        
        
    </body>
</html>